Protocol and Statistical Analysis Plan for the Vasopressin for Septic Shock Pragmatic (VASSPR) Cluster-Crossover Randomized Trial
CHEST Critical Care · 2025-12 · 3 (4) · 100178
DOI: 10.1016/j.chstcc.2025.100178 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift CHEST Critical Care, 2025-12. Verfasst von Ithan D Peltan und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine (I. D. P., D. G., J. R. J., E. H. T., S. J. B., J. H. E., N. A., E. L. H., J. R. C., M. J. L., C. …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, Intermountain Research and Medical Foundation, University of Utah.
Themen: Sepsis
Abstract (Originalsprache)
BACKGROUND: Guidelines recommend vasopressin as the preferred second-line vasopressor for treatment of septic shock. However, the optimal threshold for vasopressin initiation is unclear. RESEARCH QUESTION: Does a treatment strategy using a lower or a higher threshold for initiation of vasopressin as a secondary vasopressor decrease the incidence of 28-day mortality for patients with septic shock? STUDY DESIGN AND METHODS: The Vasopressin for Septic Shock Pragmatic (VASSPR) trial is a multicenter, open-label, cluster-randomized, multiple cluster-crossover pragmatic clinical trial being conducted in 13 hospitals in Utah and Idaho. The trial compares a strategy for septic shock management recommending initiation of fixed-dose vasopressin as a secondary vasopressor at a lower threshold (when the total dose of other vasopressors reaches 0.1 mg/kg/min norepinephrine equivalents [NEEs]) to a strategy initiating vasopressin at a higher threshold (when other vasopressors reach 0.4 mg/kg/min NEEs). All adult patients with septic shock at study hospitals are enrolled in the trial and assigned to the treatment strategy in place at the study hospital when and where they start vasopressor treatment for suspected or confirmed septic shock. Individual patient care, including adherence to the assigned vasopressin initiation strategy, occurs at the discretion of each patient's treating clinicians. The primary outcome is 28-day all-cause mortality. The key secondary outcome is renal replacement therapy-free days to day 28. RESULTS: This article describes the protocol and statistical analysis plan for the conduct and analysis of the VASSPR trial. INTERPRETATION: The VASSPR trial will provide important data to guide vasopressor management for patients with septic shock. Prespecification of the trial protocol and statistical analysis plan before completion of enrollment is important for rigorous trial conduct and reporting. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT06217562; URL: www.clinicaltrials.gov.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine (I. D. P., D. G., J. R. J., E. H. T., S. J. B., J. H. E., N. A., E. L. H., J. R. C., M. J. L., C. K., C. K. G., S. M. B., and L. M. L.), the Department of Pharmacy (S.…
Förderung
- NCATS NIH HHS
- Intermountain Research and Medical Foundation
- University of Utah
- National Center for Advancing Translational Sciences
Zitieren
APA
Peltan, I. D., Groat, D., Jacobs, J. R., Tillman, E. H., Brintz, B. J., Chauv, S., Beesley, S. J., Edwards, J. H., Arizmendez, N., Hirshberg, E. L., Carr, J. R., Lanspa, M. J., Bledsoe, J. R., Smith, A. T., Schneider, H., Hu, P., Moores Todd, T. D., Klippel, C., Semler, M. W., …, & Leither, L. M. (2025). Protocol and Statistical Analysis Plan for the Vasopressin for Septic Shock Pragmatic (VASSPR) Cluster-Crossover Randomized Trial. CHEST Critical Care, 3(4), 100178. https://doi.org/10.1016/j.chstcc.2025.100178
Vancouver
Peltan ID, Groat D, Jacobs JR, Tillman EH, Brintz BJ, Chauv S, et al. Protocol and Statistical Analysis Plan for the Vasopressin for Septic Shock Pragmatic (VASSPR) Cluster-Crossover Randomized Trial. CHEST Critical Care. 2025;3(4):100178. doi:10.1016/j.chstcc.2025.100178
BibTeX
@article{Peltan2025,
author = {Peltan, Ithan D and Groat, Danielle and Jacobs, Jason R and Tillman, Elisabeth H and Brintz, Ben J and Chauv, Stephanie and Beesley, Sarah J and Edwards, Jennifer H and Arizmendez, Natalia and Hirshberg, Eliotte L and Carr, Jason R and Lanspa, Michael J and Bledsoe, Joseph R and Smith, Austin T and Schneider, Harmony and Hu, Ping and Moores Todd, Tamara D and Klippel, Carolyn and Semler, Matthew W and Casey, Jonathan W and Grissom, Colin K and Brown, Samuel M and Leither, Lindsay M},
title = {Protocol and Statistical Analysis Plan for the Vasopressin for Septic Shock Pragmatic (VASSPR) Cluster-Crossover Randomized Trial},
journal = {CHEST Critical Care},
year = {2025},
volume = {3},
number = {4},
pages = {100178},
doi = {10.1016/j.chstcc.2025.100178}
}
EUVIMED